Ropivacaine
- Generic Name
- Ropivacaine
- Brand Names
- Naropin
- Drug Type
- Small Molecule
- Chemical Formula
- C17H26N2O
- CAS Number
- 84057-95-4
- Unique Ingredient Identifier
- 7IO5LYA57N
- Background
Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
- Indication
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
- Associated Conditions
- Acute Pain, Postoperative pain
- Associated Therapies
- Surgical anesthesia therapy
Anesthesia And Post-operative Mortality After Proximal Femur Fractures
- Conditions
- Interventions
- First Posted Date
- 2015-04-02
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- Centro Hospitalar do Porto
- Target Recruit Count
- 57
- Registration Number
- NCT02406300
- Locations
- 🇵🇹
Serviço de Anestesiologia - Centro Hospitalar do Porto, Porto, Portugal
Effect of Epidural Analgesia on the Length of Labor and Delivery and Fetal Outcomes
- Conditions
- Interventions
- First Posted Date
- 2015-03-24
- Last Posted Date
- 2016-03-09
- Lead Sponsor
- University of Cagliari
- Target Recruit Count
- 100
- Registration Number
- NCT02396563
Supraclavicular Brachial Plexus Block Using Ropivacaine Alone and With Dexmedetomidine
- Conditions
- Interventions
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2015-11-06
- Lead Sponsor
- Government Medical College, Haldwani
- Target Recruit Count
- 80
- Registration Number
- NCT02393677
A Comparative Study of the Effect of Epidural Dexmedetomidine Versus Fentanyl Added to Ropivacaine in Pediatric Orthopedic Surgery
- Conditions
- Interventions
- First Posted Date
- 2015-03-02
- Last Posted Date
- 2016-08-17
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 58
- Registration Number
- NCT02375191
- Locations
- 🇰🇷
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of
The Analgesic Effect of Combined Nerve Block and Systemic High Dose Glucocorticoid After Total Knee Arthroplasty.
- First Posted Date
- 2015-02-27
- Last Posted Date
- 2015-11-30
- Lead Sponsor
- Regionshospitalet Silkeborg
- Target Recruit Count
- 74
- Registration Number
- NCT02374008
Exparel vs Exparel Plus ACB in TKAs
- Conditions
- Interventions
- First Posted Date
- 2015-02-19
- Last Posted Date
- 2016-01-14
- Lead Sponsor
- The Hawkins Foundation
- Registration Number
- NCT02365727
- Locations
- 🇺🇸
Steadman Hawkins Clinic of the Carolinas - Greenville Health System, Greenville, South Carolina, United States
Paravertebral Catheters for VATS Procedures
- Conditions
- Interventions
- First Posted Date
- 2015-02-12
- Last Posted Date
- 2015-02-12
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 50
- Registration Number
- NCT02361775
Adductor Canal Block Versus Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction Arthroscopically
- Conditions
- Interventions
- First Posted Date
- 2015-02-04
- Last Posted Date
- 2015-02-04
- Target Recruit Count
- 40
- Registration Number
- NCT02355093
The T REX Pilot Study: a Study to Investigate the Use of an Alternative Anaesthetic in Infants.
- Conditions
- Interventions
- First Posted Date
- 2015-02-02
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 60
- Registration Number
- NCT02353182
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
🇸🇬KK Women's and Children's Hospital, Singapore, Singapore
Ultrasound-Guided Obturator Nerve Block for Ambulatory Hip Arthroscopy
- Conditions
- Interventions
- First Posted Date
- 2015-01-27
- Last Posted Date
- 2015-01-27
- Lead Sponsor
- Benaroya Research Institute
- Target Recruit Count
- 70
- Registration Number
- NCT02346357
- Locations
- 🇺🇸
Virginia Mason Medical Center, Seattle, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.